Literature DB >> 436919

Relationship between dose and plasma level of digoxin and patient characteristics.

N Heinz, N Rietbrock.   

Abstract

The correlation between the daily dose of digoxin, its plasma level and clinical characteristics of 213 patients receiving beta-acetyldigoxin treatment has been evaluated. After logarithmic transformation of lognormally distributed variables multiple linear regression analysis was performed. Eight predictor variables were chosen: sex, age, height, weight, glycoside dose, creatinine and potassium level in serum and dose of spironolactone. The resulting correlation coefficient was 0.46, i.e. only 100 x r2 = 21.4% of the variance of the steady state digoxin plasma level could be interpreted with the aid of these variables. For only 4 of the 8 variables (age, glycoside dose, serum level of creatinine, and spironolactone dose) were partial coefficients of regression and of correlation significantly different from zero. Almost 80% of the variance could not be accounted for. This finding is in accordance with conclusions in the literature.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436919     DOI: 10.1007/bf00609873

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  [Glycoside-plasma level under maintenance therapy--dispersion of the concentrations and its causes].

Authors:  J Kuhlmann; N Rietbrock
Journal:  Verh Dtsch Ges Inn Med       Date:  1976

2.  Myocardial distribution of digoxin and renal function.

Authors:  W J Jusko; M Weintraub
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

3.  Computer-assisted digoxin therapy.

Authors:  C C Peck; L B Sheiner; C M Martin; D T Combs; K L Melmon
Journal:  N Engl J Med       Date:  1973-08-30       Impact factor: 91.245

4.  Factors that regulate ouabain-H3 accumulation by the isolated guinea-pig heart.

Authors:  S Dutta; B H Marks
Journal:  J Pharmacol Exp Ther       Date:  1969-12       Impact factor: 4.030

5.  An improved method of digoxin therapy.

Authors:  R W Jelliffe
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

6.  [Digoxon or digitoxin in patients with terminal kidney insufficiency in the dialysis stage?].

Authors:  T Risler; U Peters; B Grabensee; W P Fritsch; T U Hausamen; F Grosse-Brockhoff
Journal:  Verh Dtsch Ges Inn Med       Date:  1977 Apr 17-21

7.  Species and ionic influences on the accumulation of digitalis glycosides by isolated perfused hearts.

Authors:  S Dutta; B H Marks
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

Review 8.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

9.  [Blood digoxin and treatment of heart failure in aged patients].

Authors:  P Jouannot; J Lavabre; M Thomas; P Y Hatt
Journal:  Arch Mal Coeur Vaiss       Date:  1976-10

10.  Sodium-dependent cardiac glycoside binding: experimental evidence and hypothesis.

Authors:  U Fricke; W Klaus
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

View more
  3 in total

1.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

2.  Clinical implications of serum digoxin concentrations.

Authors:  H R Ochs; D J Greenblatt; J S Harmatz; G Bodem; H J Dengler
Journal:  Klin Wochenschr       Date:  1981-05-15

3.  Pharmacokinetics of digoxin in pregnancy.

Authors:  A M Luxford; G S Kellaway
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.